|
Press Releases |
|
 |
|
Friday, June 7, 2019 |
|
PromarkerD features at American Diabetes Association 79th Scientific Sessions saying diabetics deserve to know their future kidney disease status |
Proteomics International (ASX: PIQ) has been invited to feature on the American Diabetes Association (ADA) TV News Network as a key opinion leader (KOL) on diabetic kidney disease diagnostics, which includes an update on PromarkerD, during the ADA 79th Scientific Sessions conference in San Francisco, June 7-11, 2019. more info >> |
|
Monday, June 3, 2019 |
|
Proteomics International and PromarkerD at BIO 2019 saying 30 million diabetics in US deserve to know their future kidney disease status |
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) will have a stand #2349 at the BIO International Convention (Philadelphia, June 3-6, 2019). more info >> |
|
Monday, June 4, 2018 |
|
Proteomics國際與PrismHealthDx 締約在美國啟動PromarkerD糖尿病腎臟疾病預測測試 |
醫藥技術公司Proteomics國際(Proteomics國際實驗室有限公司;ASX: PIQ)已經與美國精密醫療和診斷服務實驗室PrismHealthDx 股份有限公司( PHDx )簽署了首個許可協議,聯手在美國啟動全球領先的PromarkerD糖尿病腎病預測測試。 more info >> |
|
Proteomics国际与PrismHealthDx 缔约在美国启动PromarkerD糖尿病肾脏疾病预测测试 |
医药技术公司Proteomics国际(Proteomics国际实验室有限公司;ASX: PIQ)已经与美国精密医疗和诊断服务实验室PrismHealthDx 股份有限公司(PHDx )签署了首个许可协议,联手在美国启动全球领先的PromarkerD糖尿病肾病预测测试。 more info >> |
|
Proteomics International signs with PrismHealthDx for US launch of PromarkerD predictive test for diabetic kidney disease |
Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has signed the first licence agreement for its world-leading PromarkerD predictive test for diabetic kidney disease in the United States. more info >> |
|
Tuesday, March 20, 2018 |
|
PromarkerD Diagnostic Test Leader Officially Launched |
Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has announced the official product launch of its world leading predictive diagnostic test for diabetic kidney disease, "PromarkerD". more info >> |
|
Monday, February 12, 2018 |
|
Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services |
MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR's share capital through the issue of 4 million PIQ shares. more info >> |
|
Monday, June 12, 2017 |
|
Clinical Validation Results confirm PromarkerD can predict Diabetic Kidney Disease better than any Current Measure |
Proteomics International Laboratories Ltd (ASX: PIQ) (PILL) announced today results from its validation clinical study showing that the PromarkerD blood test can predict the onset of diabetic kidney disease better than any current measure. more info >> |
|
Tuesday, March 28, 2017 |
|
Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Diabetic Kidney Disease |
Proteomics International Laboratories Ltd (PILL; ASX:PIQ) is the leader in predictive diagnostics for diabetic kidney disease, according to an independent Frost & Sullivan report released this month. more info >> |
|
Monday, March 27, 2017 |
|
Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Diabetic Kidney Disease |
Proteomics International Laboratories Ltd (PILL; ASX:PIQ) is the leader in predictive diagnostics for diabetic kidney disease, according to an independent Frost & Sullivan report released this month. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 22:33 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 13, 2025 22:31 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 13, 2025 21:32 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 21:30 HKT/SGT
|
|
|
NMPA已受理亿胜生物关于EB12-20145P(HLX04-O)用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Aug 13, 2025 21:25 HKT/SGT
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 20:24 HKT/SGT
|
|
|
NMPA已受理億勝生物關於EB12-20145P(HLX04-O)用於治療濕性年齡相關性黃斑變性的生物製品許可申請
Aug 13, 2025 20:24 HKT/SGT
|
|
|
潼關黃金獲納入MSCI全球小型股指數 資本市場影響力進一步提升
Aug 13, 2025 19:19 HKT/SGT
|
|
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 15:33 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 14:18 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 13:00: JST
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 11:00 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸運觀眾現場觀賽 深度參與世界人形機器人運動會
Aug 13, 2025 09:58 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|